在A型急性大动脉剖析的紧急手术中去除阿皮克萨班:一项前性队列研究
Henriette Røed-Undlien1, Nina H Schultz2,3, Inger M Husebråten4
1Institute of Clinical Medicine, University of Oslo.
International journal of surgery (London, England)
|January 14, 2025
概括
在急救大动脉修复手术期间,手术内血吸显著降低了阿皮克萨班水平. 需要进行进一步的研究,以评估其对急性甲型大动脉剖析患者出血和死亡率的影响.
科学领域:
- 心血管外科心血管外科
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 急性A型大动脉解剖 (ATAAD) 携带高死亡率,需要紧急的手术修复.
- 在ATAAD修复期间管理FXa抑制剂抗凝药 (例如,阿皮克萨班) 需要平衡出血风险与血栓事件.
- 术内血吸血是一种减轻出血的潜在策略,但其对抗凝血效应需要评估.
研究的目的:
- 为了研究手术内血液吸收对血阿皮克萨班度的影响,在患者接受紧急胸前大动脉修复的ATAAD.
主要方法:
- 一个单一中心前性队列研究,涉及八名ATAAD患者接受阿皮克萨班治疗.
- 使用UPLC-MS在多个时间点测量阿皮克萨班水平,在心肺绕道 (CPB) 期间和之后与血液吸收 (CytoSorb).
主要成果:
- 在30分钟的CPB (108至44μg/l) 后,血吸降低了59%的阿皮克萨班平均度.
- 在CPB断奶后观察到进一步降低至37μg/l,术后24小时水平增加至56μg/l.
- 住院死亡率为25%,平均24小时胸管排水量为621毫升.
结论:
- 在接受紧急ATAAD修复的患者中,手术内血液吸收有效降低了手术内阿皮克萨班水平.
- 这种减少外科手术期间出血和死亡率的临床意义需要进一步调查.
- 这项研究强调了在ATAAD患者使用血吸时需要量身定制的抗凝管理策略.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607


